Validation of a Greek memory and thinking test
Part of Brain & nervous system, Mental health clinical trials.
This study is testing a Greek-language version of a memory and thinking test (called MoCA) to see how well it works. If you are between 55 and 85 and speak Greek fluently, you may be able to help validate this screening tool.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 55 and 85 years old.
- You are fluent in Greek (able to understand and speak it easily).
- You can agree (give informed consent) to participate.
- You do not have a history of severe brain or mental health conditions (except mild memory loss or dementia).
- You are not currently sick with an acute medical illness.
- You do not have severe hearing or vision problems that would make testing difficult.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new questionnaire that helps doctors check for memory and thinking problems in older adults who speak Arabic. It is designed to be more accurate and easier to use than current methods.
This study tests whether an online cognitive assessment platform (Creyos) is valid for older adults with major depression or mild cognitive impairment. Participants will complete brain games or puzzles to see how well the online tool measures thinking skills.
This study uses a computer-based platform to test memory and thinking in healthy adults and in people with mild memory concerns (called aMCI). The goal is to better understand how memory changes with age and to spot early signs of Alzheimer's disease.
This study is testing new questionnaires to better understand everyday thinking and memory problems in older adults. It aims to improve how doctors identify and track conditions like mild cognitive impairment and early dementia.
This study is testing whether simple digital memory tests and blood tests can help find people who might qualify for anti-amyloid treatments (medications that target Alzheimer's-related proteins). It aims to make screening easier and faster, without needing a spinal tap or PET scan.
This study looks at how common mild cognitive impairment and dementia are in people staying in rehabilitation units for heart, lung, or orthopedic problems. It aims to understand memory and thinking issues that may be overlooked in these settings.
Hear when a new MCI trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.